Upcoming studies of CAR-T in breast cancer include a phase I/II (NCT04020575) study targeting metastatic breast cancer expressing Muc1 growth factor receptor, called Muc1*, and a phase I study (NCT02706392) of CAR-T in liquid and solid malignancies expressing ROR1. The gene discussed is MUC1; the disease is breast carcinoma.